Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · IEX Real-Time Price · USD
109.01
+0.17 (0.16%)
At close: Jul 19, 2024, 4:00 PM
109.06
+0.05 (0.05%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Jazz Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2004
Revenue
3,8433,8343,6593,0942,3642,162
Upgrade
Revenue Growth (YoY)
2.81%4.78%18.26%30.91%9.34%14.32%
Upgrade
Cost of Revenue
402.42435.58540.52440.76148.92127.93
Upgrade
Gross Profit
3,4413,3993,1192,6532,2152,034
Upgrade
Selling, General & Admin
1,3971,3431,4171,452854.23736.94
Upgrade
Research & Development
883.1849.66590.45505.75335.38299.73
Upgrade
Other Operating Expenses
642.23627.281,177525.77646.97464.79
Upgrade
Operating Expenses
2,9222,8203,1842,4831,8371,501
Upgrade
Operating Income
518.73578.58-65.53170.28378.07532.37
Upgrade
Interest Expense / Income
281.41289.44288.24278.7799.7172.26
Upgrade
Other Expense / Income
-0.55-5.7828.945.066.239.9
Upgrade
Pretax Income
237.88294.92-382.71-113.55272.13450.21
Upgrade
Income Tax
-92.92-119.91-158.65216.1233.52-73.15
Upgrade
Net Income
330.79414.83-224.06-329.67238.62523.37
Upgrade
Net Income Growth
-----54.41%17.06%
Upgrade
Shares Outstanding (Basic)
636363605657
Upgrade
Shares Outstanding (Diluted)
637263605758
Upgrade
Shares Change
-15.23%15.23%4.77%5.62%-1.79%-6.00%
Upgrade
EPS (Basic)
5.236.55-3.58-5.524.289.22
Upgrade
EPS (Diluted)
4.866.10-3.58-5.524.229.09
Upgrade
EPS Growth
-----53.58%24.52%
Upgrade
Free Cash Flow
1,0111,0681,243750.87884.64750.48
Upgrade
Free Cash Flow Per Share
16.1716.8819.8712.5815.8813.22
Upgrade
Gross Margin
89.53%88.64%85.23%85.76%93.70%94.08%
Upgrade
Operating Margin
13.50%15.09%-1.79%5.50%16.00%24.63%
Upgrade
Profit Margin
8.61%10.82%-6.12%-10.65%10.10%24.21%
Upgrade
Free Cash Flow Margin
26.32%27.86%33.97%24.27%37.43%34.72%
Upgrade
Effective Tax Rate
-39.06%-40.66%--12.32%-16.25%
Upgrade
EBITDA
1,1641,223535.01717.7650.09892.63
Upgrade
EBITDA Margin
30.29%31.90%14.62%23.19%27.50%41.29%
Upgrade
Depreciation & Amortization
644.72638.7629.47552.48278.25370.16
Upgrade
EBIT
519.28584.36-94.46165.21371.84522.47
Upgrade
EBIT Margin
13.51%15.24%-2.58%5.34%15.73%24.17%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).